DailyDoctor Archive Specialties Get app
All emergency & critical care briefings

The edition · Emergency & Critical Care

Cephalosporin generation showed no difference in outpatient pyelonephritis

First-generation oral cephalosporins did as well as later generations for pyelonephritis discharged from the ED, cuff and arterial line pressures often disagree on vasopressors, arginine failed in sickle cell crises, and open ICU visiting and delirium.

The edition in brief

The edition closes on DOGMA-ED, a retrospective study of 1147 adults discharged from 11 US emergency departments on an oral cephalosporin for pyelonephritis. Fourteen-day treatment failure was about 18% to 20% whether patients received a first-, second- or third-generation agent, mostly cephalexin, cefuroxime or cefdinir. It is observational and from a low-resistance setting, so local resistance, particularly ESBL rates in India, should still drive the choice. In 13 Polish ICUs, almost one in five patients on vasoactive drugs had a brachial cuff mean pressure more than 11 mmHg away from the radial arterial line, linked to higher noradrenaline doses and higher mortality. The phase 3 STArT trial of intravenous arginine for sickle cell pain crises in 271 children and young adults stopped for futility, with no change in time to crisis resolution or opioid use. A meta-analysis of 13 randomised trials found open or flexible ICU visiting was associated with about half the rate of delirium (RR 0.48) without more infection, at low certainty. The pearl covers euglycaemic ketoacidosis in patients taking SGLT2 inhibitors.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free